[1]
Garcia-Tsao, G.; Abraldes, J.G.; Berzigotti, A.; Bosch, J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 2017, 65(1), 310-335.
[http://dx.doi.org/10.1002/hep.28906] [PMID: 27786365]
[http://dx.doi.org/10.1002/hep.28906] [PMID: 27786365]
[2]
de Franchis, R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol., 2015, 63(3), 743-752.
[http://dx.doi.org/10.1016/j.jhep.2015.05.022] [PMID: 26047908]
[http://dx.doi.org/10.1016/j.jhep.2015.05.022] [PMID: 26047908]
[3]
Yi, F.; Guo, X.; Wang, L.; Xu, X.; An, Y.; Tang, Y.; Zhang, W.; Tacke, F.; Arora, A.; Qi, X. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis. J. Gastroenterol. Hepatol., 2021, 36(6), 1694-1702.
[http://dx.doi.org/10.1111/jgh.15386] [PMID: 33393106]
[http://dx.doi.org/10.1111/jgh.15386] [PMID: 33393106]
[4]
Lam, K.C.; Juttner, H.U.; Reynolds, T.B. Spontaneous portosystemic shunt: Relationship to spontaneous encephalopathy and gastrointestinal hemorrhage. Dig. Dis. Sci., 1981, 26(4), 346-352.
[http://dx.doi.org/10.1007/BF01308377] [PMID: 6972295]
[http://dx.doi.org/10.1007/BF01308377] [PMID: 6972295]
[5]
An, J.; Kim, K.W.; Han, S.; Lee, J.; Lim, Y.S. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment. Pharmacol. Ther., 2014, 39(12), 1418-1426.
[http://dx.doi.org/10.1111/apt.12771] [PMID: 24754260]
[http://dx.doi.org/10.1111/apt.12771] [PMID: 24754260]
Article Metrics
4